Overview
Achraf Shamseddine is a Radiation Oncologist practicing medicine in Commack, New York.
Dr. Shamseddine is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Laryngeal Cancer, and Throat Cancer.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles. Dr. Shamseddine is currently accepting new patients.
Specialties
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
650 Commack Rd, Commack, NY 11725
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Narek Shaverdian is a Radiation Oncologist practicing medicine in Commack, New York. Dr. Shaverdian is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Gastrostomy. Dr. Shaverdian is currently accepting new patients.
Memorial Sloan Kettering Cancer Center
Andreas Rimner is a Radiation Oncologist practicing medicine in New York, New York. Dr. Rimner is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Tissue Biopsy, and Thymectomy.
Memorial Sloan Kettering Cancer Center
Daniel Gomez is a Radiation Oncologist practicing medicine in New York, New York. Dr. Gomez is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Mesothelioma. Dr. Gomez is currently accepting new patients.
Frequently Asked Questions about Dr. Achraf Shamseddine
How do I make an appointment with Dr. Achraf Shamseddine?
You can book an appointment with Dr. Achraf Shamseddine by calling their office at 518-243-8667. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Achraf Shamseddine a top-rated expert for Primitive Neuroectodermal Tumor (PNET)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Achraf Shamseddine is classified as an Advanced expert for Primitive Neuroectodermal Tumor (PNET), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Achraf Shamseddine specialize in?
While Dr. Achraf Shamseddine is a Radiation Oncology, they have specific expertise in Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Laryngeal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Achraf Shamseddine participate in research or clinical trials?
Yes. Dr. Achraf Shamseddine has published 31 articles and abstracts on conditions like Primitive Neuroectodermal Tumor (PNET). You can view a list of Dr. Achraf Shamseddine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Achraf Shamseddine accept my insurance?
Dr. Achraf Shamseddine accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 518-243-8667 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adenoid Cystic CarcinomaDr. Shamseddine isAdvanced. Learn about Adenoid Cystic Carcinoma.
- GliomaDr. Shamseddine isAdvanced. Learn about Glioma.
- Laryngeal CancerDr. Shamseddine isAdvanced. Learn about Laryngeal Cancer.
- Merkel Cell CarcinomaDr. Shamseddine isAdvanced. Learn about Merkel Cell Carcinoma.
- Posterior Fossa TumorDr. Shamseddine isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Shamseddine isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Shamseddine isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- ALK-Positive Non-Small Cell Lung CancerDr. Shamseddine isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Shamseddine isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Shamseddine isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Shamseddine isExperienced. Learn about Anal Cancer.
- Anaplastic Large Cell LymphomaDr. Shamseddine isExperienced. Learn about Anaplastic Large Cell Lymphoma.